By Dr Deborah Marriott

Journal articles

Baysari M; Brett J; Lam V; Milder T; Killen L; Chau AMT; McMullan B; Harkness J; Marriot D; Day R, 2013, 'Pneumonia Severity Scores and Prescribing Antibiotics for Community-Acquired Pneumonia at an Australian Hospital', Journal of Pharmacy Practice and Research, 43, pp. 97 - 101

Neoh CF; Liew D; Slavin MA; Marriott D; Chen SCA; Morrissey O; Stewart K; Kong DCM, 2013, 'Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis', Internal Medicine Journal, 43, pp. 668 - 677, http://dx.doi.org/10.1111/imj.12110

Chapman JR; Marriott DJ; Chen SCA; MacDonald PS, 2013, 'Post-transplant Pneumocystis jirovecii pneumonia - A re-emerged public health problem?', Kidney International, 84, pp. 240 - 243, http://dx.doi.org/10.1038/ki.2013.212

Brett J; Chong O; Graham GG; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Antifungal Use and Therapeutic Monitoring of Plasma Concentrations of Itraconazole in Heart and Lung Transplantation Patients.', Therapeutic Drug Monitoring, 35, pp. 133 - 136, http://dx.doi.org/10.1097/FTD.0b013e318275fe69

Wong C; Kumar SS; Graham GG; Begg EJ; Chin P; Brett J; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Comparing dose prediction software used to manage gentamicin dosing', Internal Medicine Journal, 43, pp. 519 - 525, http://dx.doi.org/10.1111/imj.12067

Burrows FS; Carlos LM; Marriott D; Havryk A; Plit M; Glanville AR, 2013, 'Oral Ribavirin Is a Cost-Effective Alternative to Intravenous Ribavirin for Respiratory Syncytial Virus (RSV) Infection after Lung Transplantation (LTx)', The Journal of Heart and Lung Transplantation, 32, pp. S109 - S109, http://dx.doi.org/10.1016/j.healun.2013.01.1043

Leenders FJ; Amin J; Bloch M; Pett SL; Marriott D; Carr AD, 2013, 'Skeletal muscle toxicity associated with raltegravir-based combination antiretroviral therapy in HIV-infected adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 62, pp. 525 - 533, http://dx.doi.org/10.1097/QAI.0b013e3182832578

Nagata N; Marriott D; Harkness J; Ellis JT; Stark D, 2012, 'Current treatment options for Dientamoeba fragilis infections', International Journal for Parasitology: Drugs and Drug Resistance, 2, pp. 204 - 215, http://dx.doi.org/10.1016/j.ijpddr.2012.08.002

McMullan BJ; Halliday C; Sorrell TC; Judd D; Sleiman S; Marriott D; Olma T; Chen SCA, 2012, 'Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory', PLoS ONE, 7, pp. e49541, http://dx.doi.org/10.1371/journal.pone.0049541

Chen SCA; Slavin MA; Heath CH; Geoffrey Playford E; Byth K; Marriott D; Kidd SE; Bak N; Currie B; Hajkowicz K; Korman TM; McBride WJH; Meyer W; Murray R; Sorrell TC, 2012, 'Clinical manifestations of cryptococcus gattii infection: Determinants of neurological sequelae and death', Clinical Infectious Diseases, 55, pp. 789 - 798, http://dx.doi.org/10.1093/cid/cis529

Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W, 2012, 'Identification of Novel Hybrids Between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII', Mycopathologia, 173, pp. 337 - 346, http://dx.doi.org/10.1007/s11046-011-9491-x

Dolton MJ; Ray JE; Marriott D; McLachlan AJ, 2012, 'Posaconazole exposure-response relationship: Evaluating the utility of therapeutic drug monitoring', Antimicrobial Agents and Chemotherapy, 56, pp. 2806 - 2813, http://dx.doi.org/10.1128/AAC.05900-11

Neoh CF; Liew D; Slavin M; Marriott D; Chen SCA; Morrissey O; Stewart K; Kong DCM, 2012, 'Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis', Journal of Antimicrobial Chemotherapy, 67, pp. 1052, http://dx.doi.org/10.1093/jac/dkr577

Stark D; Roberts T; Marriott D; Harkness J; Ellis JT, 2012, 'Detection and transmission of Dientamoeba fragilis from environmental and household samples', American Journal of Tropical Medicine and Hygiene, 86, pp. 233 - 236, http://dx.doi.org/10.4269/ajtmh.2012.11-0526

Nagata N; Marriott D; Harkness J; Ellis JT; Stark D, 2012, 'In vitro susceptibility testing of Dientamoeba fragilis', Antimicrobial Agents and Chemotherapy, 56, pp. 487 - 494, http://dx.doi.org/10.1128/AAC.05125-11

Periyasamy P; Marriott D, 2012, 'A retrospective review of staphylococcal infections in St Vincent's Hospital 2006-2007', International Journal of Infectious Diseases, 16, pp. e236 - e236, http://dx.doi.org/10.1016/j.ijid.2012.05.853

Botes LP; Pett SL; Carr AD; Marriott D; Cooper DA; Matthews G; Carbone S; Kumaradevan N; Mchugh L; Hillman R, 2012, 'Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with men.', Sexual Health, 10, pp. 9 - 17, http://dx.doi.org/10.1071/SH11135

McMullan B; Marriott D, 2011, 'Reply to "fatal Prototheca wickerhamii bloodstream infection in a cardiac allograft recipient"', Journal of Clinical Microbiology, 49, pp. 4025, http://dx.doi.org/10.1128/JCM.05509-11

Neoh CF; Liew D; Slavin M; Marriott D; Chen SCA; Morrissey O; Stewart K; Kong DCM, 2011, 'Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis', Journal of Antimicrobial Chemotherapy, 66, pp. 1906 - 1915, http://dx.doi.org/10.1093/jac/dkr186

Ray J; Campbell L; Rudham S; Nguyen Q; Marriott D, 2011, 'Posaconazole plasma concentrations in critically ill patients', Therapeutic Drug Monitoring, 33, pp. 387 - 392, http://dx.doi.org/10.1097/FTD.0b013e31821fb197

McMullan B; Muthiah K; Stark D; Lee L; Marriott D, 2011, 'Prototheca wickerhamii mimicking yeast: A cautionary tale', Journal of Clinical Microbiology, 49, pp. 3078 - 3081, http://dx.doi.org/10.1128/JCM.00487-11

Banik GR; Barratt JLN; Marriott D; Harkness J; Ellis JT; Stark D, 2011, 'A case-controlled study of Dientamoeba fragilis infections in children', Parasitology, 138, pp. 819 - 823, http://dx.doi.org/10.1017/S0031182011000448

Barratt JLN; Harkness J; Marriott D; Ellis JT; Stark D, 2011, 'The ambiguous life of Dientamoeba fragilis: the need to investigate current hypotheses on transmission.', Parasitology, 138, pp. 557 - 572, http://dx.doi.org/10.1017/S0031182010001733

Barratt JLN; Harkness J; Marriott D; Ellis JT; Stark D, 2011, 'A review of Dientamoeba fragilis carriage in humans: Several reasons why this organism should be considered in the diagnosis of gastrointestinal illness', Gut Microbes, 2, http://dx.doi.org/10.4161/gmic.2.1.14755

Marriott DJE; Periyasamy P, 2011, 'Anticonvulsant hypersensitivity syndrome secondary to lamotrigine mimicking a septic episode', Annals of the Academy of Medicine Singapore, 40, pp. 422 - 423

Stark D; Al-Qassab SE; Barratt JLN; Stanley K; Roberts T; Marriott D; Harkness J; Ellis JT, 2011, 'Evaluation of multiplex tandem real-time PCR for Detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in clinical stool samples', Journal of Clinical Microbiology, 49, pp. 257 - 262, http://dx.doi.org/10.1128/JCM.01796-10

Hillman R; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, 8, pp. 255 - 256, http://search.informit.com.au/documentSummary;dn=026919938891985;res=IELHEA

Botes LP; Jin F; Bourne CP; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews G; Brew BJ; Hillman R, 2011, 'Participants' perspectives of self-collected anal cytological swabs', Sexual Health, 8, pp. 257 - 258, http://search.informit.com.au/documentSummary;dn=026957204834502;res=IELHEA

Chaganti J; Marriott D; Steel T; Donovan JW; Biggs ND, 2011, 'Perineural trigeminal nerve abscess secondary to mucor sinusitis - serial DW MR imaging and literature review', Clinical Radiology, 66, pp. 1106 - 1109

James R; Barratt J; Marriott D; Harkness J; Stark D, 2010, 'Short report: Seroprevalence of Entamoeba histolytica infection among men who have sex with men in Sydney, Australia', American Journal of Tropical Medicine and Hygiene, 83, pp. 914 - 916, http://dx.doi.org/10.4269/ajtmh.2010.10-0231

Stark D; Barratt J; Roberts T; Marriott D; Harkness J; Ellis J, 2010, 'A review of the clinical presentation of dientamoebiasis', American Journal of Tropical Medicine and Hygiene, 82, pp. 614 - 619, http://dx.doi.org/10.4269/ajtmh.2010.09-0478

Gordon DH; Stow NW; Yapa HM; Bova R; Marriott D, 2010, 'Laryngeal cryptococcosis: Clinical presentation and treatment of a rare cause of hoarseness', Otolaryngology - Head and Neck Surgery, 142, http://dx.doi.org/10.1016/j.otohns.2009.08.030

Miyakis S; van Hal SJ; Ray J; Marriott D, 2010, 'Voriconazole concentrations and outcome of invasive fungal infections', Clinical Microbiology and Infection, 16, pp. 927 - 933, http://dx.doi.org/10.1111/j.1469-0691.2009.02990.x

Slavin M; Sorrell T; Marriott D; Thursky KA; Nguyen Q; Ellis D; Morrissey O; Chen S, 2010, 'Candidaemia in adult cancer patients: Risks for fluconazole-resistant isolates and death', Journal of Antimicrobial Chemotherapy, 65, pp. 1042 - 1051

Miyakis S; van Hal S; Solvag C; Ray J; Marriott D, 2010, 'Clinican ordering paractices for voriconazole therapeutic drug monitoring: experiences of a referral laboratory', Therapeutic Drug Monitoring, 32, pp. 661 - 664

Stark D; Barratt J; Roberts T; Marriott D; Harkness JL; Ellis J, 2010, 'Comparsion of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples', European Journal of Clinical Microbiology and Infectious Diseases, 29, pp. 411 - 416

Barratt J; Harkness JL; Ellis JT; Marriott D; Stark D, 2010, 'Importance of nonenteric protozan infections in immunocompromised people', Clinical Microbiology Reviews, 23, pp. 795 - 836

Barratt J; Banik G; Harkness JL; Marriott D; Ellis JT; Stark D, 2010, 'Newly defined conditions for the in vitro cultivation and cryopreservation of Dientamoeba fragilis: New techniques set to fast track molecular studies on this organism', Parasitology, 137, pp. 1867 - 1878

Stark D; Barratt J; Ellis J; Harkness J; Marriott D, 2009, 'Repeated Dientamoeba fragilis infections: A case report of two families from Sydney, Australia', Infectious Disease Reports, 1, pp. 7 - 9, http://dx.doi.org/10.4081/idr.2009.1280

Marriott D; Levy R; Doyle T; Ray J, 2009, 'Posaconazole-induced topiramate toxicity', Annals of Internal Medicine, 151, pp. 143, http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00018

Blyth CC; Chen SCA; Slavin MA; Serena C; Nguyen Q; Marriott D; Ellis D; Meyer W; Sorrell TC, 2009, 'Not just little adults: Candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients', Pediatrics, 123, pp. 1360 - 1368, http://dx.doi.org/10.1542/peds.2008-2055

Van Hal SJ; Marriott DJE; Chen SCA; Nguyen Q; Sorrell TC; Ellis DH; Slavin MA, 2009, 'Candidemia following solid organ transplantation in the era of antifungal prophylaxis: The Australian experience', Transplant Infectious Disease, 11, pp. 122 - 127, http://dx.doi.org/10.1111/j.1399-3062.2009.00371.x

Stark D; Van Hal S; Barratt J; Ellis J; Marriott D; Harkness J, 2009, 'Limited genetic diversity among genotypes of Enterocytozoon bieneusi strains isolated from HIV-infected patients from Sydney, Australia', Journal of Medical Microbiology, 58, pp. 355 - 357, http://dx.doi.org/10.1099/jmm.0.006445-0

Stark D; Van Hal S; Marriott D; Harkness J, 2009, 'Reply', Journal of Travel Medicine, 16, pp. 145, http://dx.doi.org/10.1111/j.1708-8305.2008.00296_2.x

Miyakis S; van Hal SJ; Barratt J; Stark D; Marriott D; Harkness J, 2009, 'Absence of human Bocavirus in bronchoalveolar lavage fluid of lung transplant patients', Journal of Clinical Virology, 44, pp. 179 - 180, http://dx.doi.org/10.1016/j.jcv.2008.10.010

Van Hal SJ; Jennings Z; Stark D; Marriott D; Harkness J, 2009, 'MRSA detection: Comparison of two molecular methods (BD GeneOhm® PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs', European Journal of Clinical Microbiology and Infectious Diseases, 28, pp. 47 - 53, http://dx.doi.org/10.1007/s10096-008-0593-4

Stark D; Barratt J; Ellis J; Harkness J; Marriott D, 2009, 'Repeated Dientamoeba fragilis infections: a case report of two families from Sydney, Australia', INFECTIOUS DISEASE REPORTS, 1, http://dx.doi.org/10.4081/idr.2009.e4

Chen S; Marriott D; Playford E; Nguyen QA; Ellis DA; Meyer W; Sorrell TC; McBride J; Coulter CL; McCormack JG; Walmsley K; Looke DF; Nimmo G; Playford G; Drummond D; Forgan Smith R; Preston E; Allworth A; Faoagali J; Gerns N; Botes J; Cherian SM; Robson J; Vohra R; O Kane GM; Robb D; Gottlieb T; Chambers I; DeWit D; Carroll M; Dobson P; Ferguson J; Graves S; Tierney L; Jozwiak F; Munro R; Tomasotos V; Pickles R; Holland J; Groenwad F; Hale K; Watson M; Vaz R; Hardiman RP; Baleriola C; Ryan S; Weeks K; Benn RA; Lawrence R; Taylor PC; Lindstrom ST; Harkness JL; Palasanthiran P; Grant R; McPetrie R; Halliday C; Maszewska K; Dennis N; Newton PJ; Franklin CA; Morrisey O; Spelman D; Wesselingh S; Speed B; Hellsten J; Mayall B; Russell J; Broughton S; Woolley I; Coloe S; Sherman A; Korman T; Huysmans M; Gordon D; Rowlands K, 2009, 'Candidaemia with uncommon Candida species: Predisposing factors, outcome, antifungal susceptibility, and implications for management', Clinical Microbiology and Infection, 15, pp. 662 - 669

Stark D; Barratt JLN; Van hal S; Marriott D; Harkness J; Ellis J, 2009, 'Clinical significance of enteric protozoa in thet immunosuppressed human population', Clinical Microbiology Reviews, 22, pp. 634 - 650

Marriott D; Playford G; Chen S; Slavin M; Nguyen QA; Ellis DA; Sorrell TC, 2009, 'Determinants of mortality in non-neutropenic ICU patients with candidaemia', Netherland Journal of Critical Care, 13

Back to profile page